A Study With Gemcitabine, Cisplatin, and LY293111 in Non-Small Cell Lung Cancer
Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effectiveness and side effects of LY293111
given in combination with gemcitabine and cisplatin in patients with non-small cell lung
cancer.